Perspectives on Biologically Active Camptothecin Derivatives
暂无分享,去创建一个
Susan L Morris-Natschke | Liu Yang | Keduo Qian | K. Lee | S. Morris-Natschke | Keduo Qian | Kuo-Hsiung Lee | Wen-Qun Li | Ying-Qian Liu | Xiang Nan | Ying-Qian Liu | Wen-Qun Li | Gao-Xiang Zhu | Xiao-Bing Wu | An-Liang Chen | Shao-Yong Zhang | Xiang Nan | Shao-yong Zhang | An-liang Chen | Liu Yang | G. Zhu | Xiao-Bing Wu
[1] J. Chern,et al. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy. , 2008, Journal of medicinal chemistry.
[2] B. Das,et al. Two efficient methods for the conversion of camptothecin to mappicine ketone, an antiviral lead compound☆ , 1998 .
[3] A. Grollman,et al. Studies on camptothecin. I. Effects of nucleic acid and protein synthesis. , 1971, Molecular pharmacology.
[4] Ying-Qian Liu,et al. Synthesis of novel derivatives of camptothecin as potential insecticides , 2010 .
[5] F. Zunino,et al. Synthesis and cytotoxic activity of substituted 7-aryliminomethyl derivatives of camptothecin. , 2004, European journal of medicinal chemistry.
[6] C. Bailly,et al. Topoisomerase I-mediated antiproliferative activity of enantiomerically pure fluorinated homocamptothecins. , 2000, Journal of medicinal chemistry.
[7] A. Bodley,et al. Antitrypanosomal activity of camptothecin analogs. Structure-activity correlations. , 1995, Biochemical pharmacology.
[8] Shengzheng Wang,et al. Synthesis and biological evaluation of novel 7-acyl homocamptothecins as Topoisomerase I inhibitors. , 2011, European journal of medicinal chemistry.
[9] Homocamptothecins: synthesis and antitumor activity of novel E-ring-modified camptothecin analogues. , 1998, Journal of medicinal chemistry.
[10] D. Blair,et al. The topoisomerase I inhibitor, camptothecin, inhibits equine infectious anemia virus replication in chronically infected CF2Th cells , 1991, Journal of virology.
[11] R. DeJager,et al. A Phase II Study of Intravenous Exatecan Mesylate (DX-8951f) Administered Daily for Five Days Every Three Weeks to Patients with Metastatic Adenocarcinoma of the Colon or Rectum , 2004, Investigational New Drugs.
[12] L. Rudnicka,et al. The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis , 2001, Arthritis research.
[13] L. Grochow,et al. Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] R J Reitemeier,et al. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer. , 1972, Cancer chemotherapy reports.
[15] Xiran Lin,et al. Effects of isocamptothecin, a novel camptothecin analogue, on proliferation, apoptosis and telomerase activity in HaCaT cells , 2008, Experimental dermatology.
[16] A. Guarino,et al. Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880). , 1970, Cancer chemotherapy reports.
[17] E. Farber,et al. Camptothecin induces differentiation, tissue transglutaminase and apoptosis in cultured keratinocytes , 1998, Experimental dermatology.
[18] H. Fiebig,et al. Design and optimization of 20-O-linked camptothecin glycoconjugates as anticancer agents. , 2001, Journal of medicinal chemistry.
[19] J. Singer,et al. Water-soluble poly-(L-glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[20] Ying-Qian Liu and. Synthesis and Insecticidal Activities of Novel Spin-Labeled Derivatives of Camptothecin. , 2012 .
[21] John H Cardellina,et al. Identification of a new natural camptothecin analogue in targeted screening for HIF-1alpha inhibitors. , 2006, Planta medica.
[22] P. Sinko,et al. ASeries of r-AminoAcid Ester Prodrugs of Camptothecin : In VitroHydrolysis and A 549 Human Lung Carcinoma Cell Cytotoxicity , 2010 .
[23] L. Keus,et al. Feasibility, phase I, and pharmacological study of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced malignancies in the lungs. , 2006, Annals of the New York Academy of Sciences.
[24] F. Zunino,et al. Gimatecan, a novel camptothecin with a promising preclinical profile , 2004, Anti-cancer drugs.
[25] Jai-Sing Yang,et al. Design, Synthesis, Mechanisms of Action, and Toxicity of Novel 20(S)-Sulfonylamidine Derivatives of Camptothecin as Potent Antitumor Agents , 2014, Journal of medicinal chemistry.
[26] Wei Guo,et al. Synthesis and evaluation of 9-benzylideneamino derivatives of homocamptothecin as potent inhibitors of DNA topoisomerase I. , 2010, European journal of medicinal chemistry.
[27] H. Li,et al. Effect of topical use of camptothecine-dimethyl sulfoxide solution in psoriasis. , 1975, Chinese medical journal.
[28] G. Bubley,et al. Microwave expedited synthesis of 5-aminocamptothecin analogs: Inhibitors of hypoxia inducible factor HIF-1alpha. , 2006, Bioorganic & medicinal chemistry letters.
[29] A. Grollman,et al. Antiviral Action of Camptothecin , 1972, Antimicrobial Agents and Chemotherapy.
[30] Y. Pommier,et al. Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1 , 2004, Cancer Research.
[31] K. Yamauchi,et al. The camptothecin derivative CPT-11 inhibits angiogenesis in a dual-color imageable orthotopic metastatic nude mouse model of human colon cancer. , 2007, Anticancer research.
[32] Y. Zu,et al. Synthesis and antitumor activity of novel 20s-camptothecin analogues. , 2009, Bioorganic & medicinal chemistry letters.
[33] C. Crumpacker,et al. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[34] F. Zunino,et al. Preclinical efficacy of ST1976, a novel camptothecin analog of the 7-oxyiminomethyl series. , 2007, Biochemical pharmacology.
[35] A. Venkateswarlu,et al. Novel C-ring analogues of 20(S)-camptothecin-part-2: synthesis and in vitro cytotoxicity of 5-C-substituted 20(S)-camptothecin analogues. , 1999, Bioorganic & medicinal chemistry letters.
[36] F. Meng,et al. 14-Aminocamptothecins: their synthesis, preclinical activity, and potential use for cancer treatment. , 2011, Journal of medicinal chemistry.
[37] S. Moro,et al. Semisynthesis, biological activity, and molecular modeling studies of C-ring-modified camptothecins. , 2009, Journal of medicinal chemistry.
[38] E K Rowinsky,et al. The current status of camptothecin analogues as antitumor agents. , 1993, Journal of the National Cancer Institute.
[39] Li-xi Yang,et al. Synthesis and pharmacology of new camptothecin drugs. , 2005, Mini-Reviews in Medical Chemistry.
[40] C. Bailly,et al. The homocamptothecin BN 80915 is a highly potent orally active topoisomerase I poison , 2001, Anti-cancer drugs.
[41] Y. Pommier. Topoisomerase I inhibitors: camptothecins and beyond , 2006, Nature Reviews Cancer.
[42] M. Cumming,et al. Antiangiogenic potential of camptothecin and topotecan , 1999, Cancer Chemotherapy and Pharmacology.
[43] Wen-Qun Li,et al. Antifeedant Activity of Camptothecin and its Semisynthetic Derivatives Against Spodoptera litura (Fabricius) (Lepidoptera: Noctuidae) Larvae , 2012 .
[44] Q. You,et al. Novel hexacyclic camptothecin derivatives. Part 1: synthesis and cytotoxicity of camptothecins with an A-ring fused 1,3-oxazine ring. , 2008, Bioorganic & medicinal chemistry letters.
[45] A. Venkateswarlu,et al. Novel C-ring analogues of 20(S)-camptothecin. Part 3: synthesis and their in vitro cytotoxicity of A-, B- and C-ring analogues. , 2000, Bioorganic & medicinal chemistry letters.
[46] L. Lou,et al. 7-Cycloalkylcamptothecin derivatives: Preparation and biological evaluation. , 2009, Bioorganic & medicinal chemistry letters.
[47] S. Sawada,et al. Synthesis and antitumor activity of 20(S)-camptothecin derivatives: A-ring modified and 7,10-disubstituted camptothecins. , 1991, Chemical & pharmaceutical bulletin.
[48] R. Kiss,et al. Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties. , 1999, Cancer research.
[49] Shannon J. Thomas,et al. On the role of E-ring oxygen atoms in the binding of camptothecin to the topoisomerase I-DNA covalent binary complex. , 2005, Bioorganic & medicinal chemistry.
[50] Shengzheng Wang,et al. Synthesis and preliminary bioevaluation of novel E-ring modified acetal analog of camptothecin as cytotoxic agents. , 2012, European journal of medicinal chemistry.
[51] H. Tian,et al. Topical Camptothecine in Treatment of Psoriasis , 1988 .
[52] S. Hecht,et al. 14-azacamptothecin: a potent water-soluble topoisomerase I poison. , 2005, Journal of the American Chemical Society.
[53] Ying-Qian Liu,et al. Anti-HSV activity of camptothecin analogues , 2010, Natural product research.
[54] Xiaoyan Chen,et al. Development and validation of a sensitive LC-MS/MS method for simultaneous quantification of sinotecan and its active metabolite in human blood. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[55] A. Demilo,et al. Camptothecin, a potent chemosterilant against the house fly. , 1974, Journal of economic entomology.
[56] Zhang Liqin,et al. Insecticidal effect of camptothecin against Nilaparvata Lugens, Brevicoryne Brassicae and Chilosuppressalis Walker. , 2009 .
[57] Shiping Zhu,et al. A new strategy to improve the metabolic stability of lactone: discovery of (20S,21S)-21-fluorocamptothecins as novel, hydrolytically stable topoisomerase I inhibitors. , 2013, Journal of medicinal chemistry.
[58] A. Lorence,et al. Camptothecin, over four decades of surprising findings. , 2004, Phytochemistry.
[59] I. Naguibneva,et al. Unusual potency of BN 80915, a novel fluorinated E-ring modified camptothecin, toward human colon carcinoma cells. , 2001, Cancer research.
[60] Min Huang,et al. Synthesis and antitumor activity of 7-ethyl-9-alkyl derivatives of camptothecin. , 2005, Bioorganic & Medicinal Chemistry Letters.
[61] M. Geng,et al. Synthesis and antitumor activity of 10-arylcamptothecin derivatives. , 2011, Bioorganic & medicinal chemistry letters.
[62] S. Segal,et al. Inhibition of retrovirus-induced disease in mice by camptothecin , 1993, Journal of virology.
[63] Zhang Li-qin. Nematocidal activity against pine wood nematode (Bursaphelenchus xylophilus) of 7-C-substituted 20-(S)-camptothecins , 2011 .
[64] S. Ahn,et al. Practical synthesis of (S)‐7‐(2‐isopropylamino)ethylcamptothecin hydrochloride, potent topoisomerase I inhibitor , 2000 .
[65] Wang Wenxiang,et al. Induced apoptosis of camptothecin in Spodoptera frugiperda Sf9 cells. , 2011 .
[66] P. Pantazis. Camptothecin: A Promising Antiretroviral Drug. , 1996, Journal of biomedical science.
[67] J. Heitman,et al. Comparison of In Vitro Activities of Camptothecin and Nitidine Derivatives against Fungal and Cancer Cells , 1999, Antimicrobial Agents and Chemotherapy.
[68] P. Pantazis,et al. 9-nitrocamptothecin selectively inhibits human immunodeficiency virus type 1 replication in freshly infected parental but not 9-nitrocamptothecin-resistant U937 monocytoid cells. , 1999, AIDS research and human retroviruses.
[69] E. De Clercq. Antiviral drugs: current state of the art. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[70] J. O’Leary,et al. Camptothecins: a review of their development and schedules of administration. , 1998, European journal of cancer.
[71] Wei Guo,et al. Synthesis and Biological Evaluation of 7‐Alkenyl Homocamptothecins as Potent Topoisomerase I Inhibitors , 2012, Chemistry & biodiversity.
[72] Zhongshan Cheng,et al. The Utility of Camptothecin as a Synergist of Bacillus thuringiensis var. kurstaki and Nucleopolyhedroviruses Against Trichoplusia ni and Spodoptera exigua , 2012, Journal of economic entomology.
[73] A. Bodley,et al. Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[74] R. Shoemaker,et al. Schedule-dependent Inhibition of Hypoxia-inducible Factor-1α Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts , 2004, Cancer Research.
[75] W. L. Hunter,et al. Topoisomerase inhibitors as anti-arthritic agents , 2008, Inflammation Research.
[76] A. Bořkovec. Control and management of insect populations by chemosterilants. , 1976, Environmental health perspectives.
[77] H. Onishi,et al. Macromolecular and nanotechnological modification of camptothecin and its analogs to improve the efficacy. , 2005, Current drug discovery technologies.
[78] Z. Cao. Preparation of 14-nitrocamptothecin derivatives by reactions of camptothecin with nitronium tetrafluoroborate in acidic solvents , 1996 .
[79] F. Zunino,et al. Synthesis and cytotoxic activity of new 9-substituted camptothecins. , 2008, Bioorganic & medicinal chemistry letters.
[80] Nicholas H Oberlies,et al. Camptothecin and taxol: historic achievements in natural products research. , 2004, Journal of natural products.
[81] A. Bhattacharjee,et al. Analysis of stereoelectronic properties of camptothecin analogues in relation to biological activity. , 2000, Bioorganic & medicinal chemistry.
[82] M. Wani,et al. Camptothecin and taxol: from discovery to clinic. , 1996, Journal of ethnopharmacology.
[83] J. Zhang,et al. The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[84] M. L. Srinivas,et al. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of an Orally Active Novel Camptothecin Analog, DRF‐1042, in Refractory Cancer Patients in a Phase I Dose Escalation Study , 2004, Journal of clinical pharmacology.
[85] H. Lerchen. Milestones in camptothecin research , 2002 .
[86] Yong-tang Zheng,et al. The Anti-HIV Actions of 7- and 10-Substituted Camptothecins , 2009, Molecules.
[87] P. Yogeeswari,et al. Camptothecin and its analogues: a review on their chemotherapeutic potential , 2005, Natural product research.
[88] Liqin Zhang,et al. Insecticidal Activity of Camptothecin Against Nilaparvata lugens, Brevicoryne brassicae, and Chilo suppressalis , 2010, Journal of economic entomology.
[89] S. Hecht,et al. Camptothecin: current perspectives. , 2004, Bioorganic & medicinal chemistry.
[90] Xiran Lin,et al. Camptothecin-mediated apoptosis and antiproliferation effect is accompanied by down-regulation of telomerase activity in HaCaT cells. , 2006, Journal of dermatological science.
[91] Shiyou Li,et al. Antifungal activity of camptothecin, trifolin, and hyperoside isolated from Camptotheca acuminata. , 2005, Journal of agricultural and food chemistry.
[92] A. K. Kondapi,et al. Neurotoxic activity of a topoisomerase-I inhibitor, camptothecin, in cultured cerebellar granule neurons. , 2010, Neurotoxicology.
[93] A. Hizi,et al. DNA-processing activities associated with the purified alpha, beta 2, and alpha beta molecular forms of avian sarcoma virus RNA-dependent DNA polymerase , 1982, Journal of virology.
[94] D. Blair,et al. Inhibition of human immunodeficiency virus (HIV-1) replication in vitro by noncytotoxic doses of camptothecin, a topoisomerase I inhibitor. , 1991, AIDS research and human retroviruses.
[95] H. Varmus,et al. Molecular biology of tumor viruses. RNA tumor viruses. , 1982 .
[96] A. McPhail,et al. Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2 , 1966 .
[97] F. Zunino,et al. Current status and perspectives in the development of camptothecins. , 2002, Current pharmaceutical design.
[98] L. Lou,et al. Semi-synthesis and biological activity of gamma-lactones analogs of camptothecin. , 2008, Bioorganic & medicinal chemistry letters.
[99] H. Kantarjian,et al. Phase I and pharmacokinetic study of a low‐clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia , 2004, Cancer.
[100] H. Hansen,et al. Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies. , 1972, Cancer chemotherapy reports.
[101] C. Conover,et al. Drug delivery systems. 2. Camptothecin 20-O-poly(ethylene glycol) ester transport forms. , 1996, Journal of medicinal chemistry.
[102] P. Pantazis,et al. Water-insoluble camptothecin analogues as potential antiviral drugs. , 1999, Journal of biomedical science.
[103] M. Wani,et al. Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogues. , 1986, Journal of medicinal chemistry.
[104] Yanning Zhang,et al. Characterization of DNA Topoisomerase-1 in Spodoptera exigua for Toxicity Evaluation of Camptothecin and Hydoxy-Camptothecin , 2013, PloS one.
[105] W. Kingsbury,et al. SYNTHESIS AND ANTI-HSV ACTIVITY OF METHYLENEDIOXY MAPPICINE KETONE ANALOGS , 1995 .
[106] S. Niizuma,et al. Synthesis of new camptothecin analogs with improved antitumor activities. , 2009, Bioorganic & medicinal chemistry letters.
[107] H. Pinedo,et al. The activity profile of the hexacyclic camptothecin derivative DX-8951f in experimental human colon cancer and ovarian cancer. , 2002, Biochemical pharmacology.
[108] S. Segal,et al. Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. , 1990, The EMBO journal.
[109] L. Saltz,et al. The camptothecins , 2003, The Lancet.
[110] C. Takimoto,et al. The Clinical Development of 9‐Aminocamptothecin , 2000, Annals of the New York Academy of Sciences.
[111] Salwa A. H. Albohy,et al. Synthesis, Spectroscopic, and Antimicrobial Activity Studies of Novel 10-Substituted Camptothecin Phosphorothioate Analogs , 2012 .
[112] Shiyou Li. Utilizing Camptotheca Products for Termite Control (US Patent 20020018762 and WO0200020) , 2002 .
[113] E. Kleinerman,et al. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[114] Yanning Zhang,et al. Effects of camptothecin and hydroxycamptothecin on insect cell lines Sf21 and IOZCAS-Spex-II. , 2012, Pest management science.
[115] R. Hertzberg,et al. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.
[116] T. Ernst,et al. Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy , 2003, Journal of NeuroVirology.
[117] P. Sinko,et al. A series of alpha-amino acid ester prodrugs of camptothecin: in vitro hydrolysis and A549 human lung carcinoma cell cytotoxicity. , 2010, Journal of medicinal chemistry.
[118] P. Houghton,et al. Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors , 2004, Cancer Chemotherapy and Pharmacology.
[119] T. Tanaka,et al. Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors. , 1987, Cancer research.
[120] Y. Nishiyama,et al. Role of DNA topoisomerase I in the replication of herpes simplex virus type 2 , 2005, Archives of Virology.
[121] Xianyong Wei,et al. Synthesis and antitumor activity of 20-O-linked nitrogen-based camptothecin ester derivatives. , 2004, Bioorganic & medicinal chemistry.
[122] F. Zunino,et al. Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts. , 2003, Molecular cancer research : MCR.
[123] A. Bodley,et al. Effects of camptothecin, a topoisomerase I inhibitor, on Plasmodium falciparum. , 1998, Biochemical pharmacology.
[124] Juan Wang,et al. Phosphate ester derivatives of homocamptothecin: synthesis, solution stabilities and antitumor activities. , 2010, Bioorganic & medicinal chemistry.
[125] D. Steverding,et al. Anti-trypanosomal activities of DNA topoisomerase inhibitors. , 2005, Acta tropica.
[126] Zhiwei Yang,et al. Synthesis and antitumor activity of novel 10-substituted camptothecin analogues. , 2006, Bioorganic & medicinal chemistry.
[127] H. Burt,et al. The effect of inhibiting topoisomerase I and II on the antiapoptotic response associated with pro-inflammatory crystals of calcium pyrophosphate dihydrate in human neutrophils , 2003, Inflammation Research.
[128] D. Scudiero,et al. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. , 2002, Cancer research.
[129] A. Venkateswarlu,et al. In vitro cytotoxicity of 5-aminosubstituted 20(S)-camptothecins. Part 1. , 1999, Bioorganic & medicinal chemistry.
[130] M. Bergeron,et al. Treatment of Visceral Leishmaniasis with Sterically Stabilized Liposomes Containing Camptothecin , 2001, Antimicrobial Agents and Chemotherapy.
[131] K. Lee,et al. Design and one-pot synthesis of new 7-acyl camptothecin derivatives as potent cytotoxic agents. , 2012, Bioorganic & medicinal chemistry letters.
[132] R. Danesi,et al. Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: a preclinical study. , 2001, Toxicology and applied pharmacology.
[133] X. Lin,et al. Topical camptothecine in treatment of psoriasis. , 1988, International journal of dermatology.
[134] Lin-jiang Tong,et al. Synthesis and biological evaluation of new homocamptothecin analogs. , 2012, European journal of medicinal chemistry.
[135] Lin Xr. Effect of camptothecin in the treatment of psoriasis , 1987 .